New research suggests patients with venous thromboembolism (VTE) have similar safety outcomes whether they receive direct oral anticoagulants (DOACs) ...
Vaccination may fail to protect young leukemia patients from developing influenza during cancer treatment, according to research published in the Jour...
LONDON—Results of a phase 2 trial suggest the topical histone deacetylase (HDAC) inhibitor remetinostat can elicit responses in patients with early st...
Biophysicists have developed a new method to determine a cell’s mechanical properties, and they believe this method could provide insights regarding c...
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) is recommending marketing authorization for lyophilized pegaspar...
Countries with the lowest opportunities for natural selection have higher cancer rates than countries with the highest opportunities for natural selec...
Results of an observational study support targeted antibacterial prophylaxis in children undergoing induction therapy for acute lymphoblastic leukemia...
Researchers say they have identified potential biomarkers that may be used to help identify patients at an increased risk of neurotoxicity after chime...
The US Food and Drug Administration (FDA) has granted fast track designation to gilteritinib for the treatment of adults with FLT3 mutation-positive r...
